Panel Discussion & Live Audience Q&A: Optimizing Drug Delivery to the Macula

Time: 9:00 am
day: Conference Day Two


  • Exploring the implications of using topical solutions for dry AMD and GA considering the spread of disease across the retina
  • Overcoming the hurdles of delivery of cell and gene therapies to understand how they can be improved to make delivery of protein therapeutics easier
  • Exploring how oral therapeutic might be the answer to achieving non-invasive retinal delivery and equal exposure to both eyes at the same time